Cysteinyl leukotrienes and their role in allergic rhinitis
Author Information
Author(s): Peters-Golden M, Gleason MM, Togias A
Hypothesis
Cysteinyl leukotrienes (CysLTs) are multi-functional mediators in allergic rhinitis.
Conclusion
CysLTs are overproduced in patients with allergic rhinitis and contribute to various symptoms and inflammatory processes associated with the condition.
Supporting Evidence
- CysLTs are released from inflammatory cells that participate in allergic rhinitis.
- CysLTs are increased in patients with allergic rhinitis and are released following allergen exposure.
- Administration of CysLTs reproduces the symptoms of allergic rhinitis.
- CysLTs play roles in the maturation and recruitment of inflammatory cells.
Takeaway
Cysteinyl leukotrienes are substances in the body that can make allergies worse, and they are found in higher amounts in people with allergic rhinitis.
Methodology
The article reviews existing data on the role of CysLTs in allergic rhinitis, including their release from inflammatory cells and effects on symptoms.
Limitations
The review is based on existing studies and may not include all recent findings.
Participant Demographics
The article discusses findings related to patients with allergic rhinitis, including those with asthma and atopy.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website